Showing results (61-70 of 160) with videos related to
Sort By:
Pageof 16
Leukemia Research|August 25, 2022
Safety and outcomes of maintenance therapy with third-generation tyrosine kinase inhibitor after allogeneic hematopoietic cell transplantation in Philadelphia chromosome positive acute lymphoblastic leukemia patients with T315I mutationHuan Chen, Lan-Ping Xu, Xiao-Hui Zhang, et al.Pediatric Transplantation|September 3, 2015
Infusion-related febrile reaction after haploidentical stem cell transplantation in children is associated with higher rates of engraftment syndrome and acute graft-versus-host diseaseYao Chen, Xiao-Jun Huang, Kai-Yan Liu, et al.Clinical Transplantation|June 14, 2016
Transplantation from haploidentical donor is not inferior to that from identical sibling donor for patients with chronic myeloid leukemia in blast crisis or chronic phase from blast crisisYan-Ru Ma, Xiao-Jun Huang, Zheng-Li Xu, et al.Acta Haematologica|January 11, 2018
Perianal Infections in the Phase before Engraftment after Allogeneic Hematopoietic Stem Cell Transplantations: A Study of the Incidence, Risk Factors, and Clinical OutcomesXiao-Dong Mo, Xia Yan, Wei Hu, et al.Clinical Transplantation|March 27, 2015
Haploidentical stem cell transplantation in patients aged 50 yr and older with leukemia: similar outcomes compared to younger adultsYao Chen, Yu Wang, Lan-Ping Xu, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2016
Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid LeukemiaLan-Ping Xu, Zheng-Li Xu, Xiao-Hui Zhang, et al.Journal of Hematology & Oncology|March 7, 2019
Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplantChen-Hua Yan, Yu Wang, Jing-Zhi Wang, et al.Cancer|March 17, 2017
Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: Long-term outcomes of a prospective randomized trialYing-Jun Chang, Yu Wang, Xiao-Dong Mo, et al.Journal of Hematology & Oncology|September 16, 2016
Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplantChen-Hua Yan, Yu Wang, Jing-Zhi Wang, et al.European Journal of Haematology|July 9, 2015
High incidence of engraftment syndrome after haploidentical allogeneic stem cell transplantationYao Chen, Lan-Ping Xu, Kai-Yan Liu, et al.Pageof 16